Document Detail


Eosinophilia-myalgia syndrome among the non-L-tryptophan users and pre-epidemic cases.
MedLine Citation:
PMID:  8895159     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Eosinophilia-myalgia syndrome (EMS) has been associated with L-tryptophan (LT) use since 1989, but as yet no etiologic agent has been identified. We describe the non-L-tryptophan associated cases of EMS, and those patients with illness onset preceding the 1989 epidemic. METHODS: Review of all patients in the EMS national state based surveillance system administered by the Centers for Disease Control and Prevention (CDC) who satisfied the EMS surveillance case definition. RESULTS: Of 1345 persons with EMS that satisfied the CDC surveillance case definition for EMS, 26 (2%) persons reported not having used LT (non-LT). Persons who did not use LT were significantly younger (mean age 39 years; p = 0.02) and were more likely than LT users to have onset of their illness before the EMS epidemic (before July 1, 1989) (p < 0.001). Non-LT users reported fewer pulmonary symptoms but had rates of neuropathy and scleroderma-like skin changes similar to LT users. Non-LT users had lower mean eosinophil counts (5.6 x 10(9) cells/I LT users 6.2 x 10(9) cells/I), reported no EMS attributable deaths, but were hospitalized (48%) more often than LT users (34%). Of the 1345 EMS cases, 191 (14%) reported a pre-epidemic illness onset. Symptoms of peripheral edema, rash, scleroderma-like skin change, alopecia, and neuropathy were more prevalent in pre-epidemic patients. Mean eosinophil count was significantly higher for epidemic patients than for pre-epidemic patients (p = 0.004). CONCLUSION: Non-LT EMS cases were more likely to be younger and to have a pre-epidemic illness onset of EMS, but otherwise were similar to LT associated EMS cases. Pre-epidemic EMS cases were more likely to report the presence of neuropathy and scleroderma-like skin change, but not pulmonary symptoms, hospitalization, or death.
Authors:
E A Sullivan; N Staehling; R M Philen
Related Documents :
17130629 - Epidemiology of the third wave of tobacco litigation in the united states, 1994-2005.
16807289 - Management of a syphilis outbreak in street sex workers in east london.
16291409 - Safety of doxycycline and minocycline: a systematic review.
9269099 - Outbreak of vampire bat biting in a venezuelan village.
15265189 - Notification of patients with acute flaccid paralysis since certification of australia ...
10812749 - Presumptive summer influenza a: an outbreak on a trans-tasman cruise.
16799319 - An unusual congenital facial anomaly: erectile proboscis-like structure.
12833029 - Auricular ossificans (ectopic ossification of the auricle).
15623969 - Pneumocephalus associated with bacteroides fragilis meningitis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of rheumatology     Volume:  23     ISSN:  0315-162X     ISO Abbreviation:  J. Rheumatol.     Publication Date:  1996 Oct 
Date Detail:
Created Date:  1997-06-03     Completed Date:  1997-06-03     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  1784-7     Citation Subset:  IM    
Affiliation:
Division of Environmental Hazards and Health Effects, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Factors
Disease Outbreaks
Eosinophilia-Myalgia Syndrome / diagnosis*
Female
Humans
Male
Middle Aged
Sex Factors
Tryptophan / adverse effects*
Chemical
Reg. No./Substance:
73-22-3/Tryptophan
Comments/Corrections
Comment In:
J Rheumatol. 1996 Oct;23(10):1679-81   [PMID:  8895138 ]
J Rheumatol. 1997 Jun;24(6):1239-40   [PMID:  9195545 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of FR133605, a novel cytokine suppressive agent, on bone and cartilage destruction in adjuvan...
Next Document:  Where does it hurt? Stability of recordings of pain location using the McGill Pain Map.